Payment overview · 2025
General Payments
$122.46
6 reported records · 5 companies
Healthcare provider profile · identity verified
Martin E. Gilliland, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · JASPER, TX · NPI 1376509190
Verified facts
What the public records show
CMS Open Payments records show Martin E. Gilliland, M.D. received $122.46 in general payments during 2025 across 6 reported records.
Novo Nordisk Inc accounted for 30.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rexulti.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Rexulti by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 168 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $36.70 | 30.0% | 2 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $35.39 | 28.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $18.27 | 14.9% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $18.25 | 14.9% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $13.85 | 11.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $122.46 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $36.70 | 2 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $35.39 | 1 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $35.39 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $21.18 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $18.27 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $18.25 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $13.85 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 168 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 18 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
168 | 46 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1029 | 279 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1022 | 237 |
| Gabapentin | Gabapentin | 765 | 210 |
| Amlodipine Besylate | Amlodipine Besylate | 673 | 190 |
| Eliquis | Apixaban | 600 | 83 |
| Lisinopril | Lisinopril | 589 | 179 |
| Metformin Hcl | Metformin Hcl | 588 | 160 |
| Pantoprazole Sodium | Pantoprazole Sodium | 505 | 145 |
| Potassium Chloride | Potassium Chloride | 501 | 132 |
| Losartan Potassium | Losartan Potassium | 484 | 137 |
| Furosemide | Furosemide | 404 | 140 |
| Clopidogrel | Clopidogrel Bisulfate | 397 | 99 |
| Alprazolam | Alprazolam | 393 | 83 |
| Hydrochlorothiazide | Hydrochlorothiazide | 371 | 98 |
| Omeprazole | Omeprazole | 355 | 111 |
| Metoprolol Succinate | Metoprolol Succinate | 350 | 94 |
| Carvedilol | Carvedilol | 324 | 80 |
| Metoprolol Tartrate | Metoprolol Tartrate | 318 | 85 |
| Citalopram Hbr | Citalopram Hydrobromide | 314 | 75 |
| Tamsulosin Hcl | Tamsulosin Hcl | 305 | 82 |
| Donepezil Hcl | Donepezil Hcl | 304 | 64 |
| Tramadol Hcl | Tramadol Hcl | 301 | 104 |
| Buspirone Hcl | Buspirone Hcl | 293 | 71 |
| Trazodone Hcl | Trazodone Hcl | 282 | 79 |
| Montelukast Sodium | Montelukast Sodium | 278 | 69 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 273 | 87 |
| Allopurinol | Allopurinol | 252 | 61 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 235 | 77 |
| Memantine Hcl | Memantine Hcl | 224 | 43 |
| Levetiracetam | Levetiracetam | 223 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 222 | 49 |
| Famotidine | Famotidine | 215 | 66 |
| Simvastatin | Simvastatin | 213 | 65 |
| Zolpidem Tartrate | Zolpidem Tartrate | 207 | 45 |
| Glipizide | Glipizide | 201 | 58 |
| Pravastatin Sodium | Pravastatin Sodium | 197 | 57 |
| Sertraline Hcl | Sertraline Hcl | 191 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 188 | 41 |
| Tizanidine Hcl | Tizanidine Hcl | 175 | 60 |
| Ozempic | Semaglutide | 168 | 46 |
| Fenofibrate | Fenofibrate Nanocrystallized | 162 | 52 |
| Divalproex Sodium | Divalproex Sodium | 143 | 40 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 140 | 30 |
| Ibuprofen | Ibuprofen | 132 | 48 |
| Alendronate Sodium | Alendronate Sodium | 129 | 32 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 125 | 34 |
| Mirtazapine | Mirtazapine | 122 | 44 |
| Pioglitazone Hcl | Pioglitazone Hcl | 121 | 34 |
| Spironolactone | Spironolactone | 121 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 118 | 38 |
| Meloxicam | Meloxicam | 118 | 42 |
| Fluoxetine Hcl | Fluoxetine Hcl | 117 | 34 |
| Clonazepam | Clonazepam | 116 | 27 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 114 | 36 |
| Prednisone | Prednisone | 113 | 69 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 111 | 41 |
| Clonidine Hcl | Clonidine Hcl | 108 | 42 |
| Hydralazine Hcl | Hydralazine Hcl | 108 | 26 |
| Xarelto | Rivaroxaban | 107 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 106 | 48 |
| Atenolol | Atenolol | 105 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 105 | 31 |
| Paroxetine Hcl | Paroxetine Hcl | 103 | 24 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 102 | 25 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 101 | 78 |
| Nifedipine Er | Nifedipine | 101 | 26 |
| Januvia | Sitagliptin Phosphate | 99 | 18 |
| Raloxifene Hcl | Raloxifene Hcl | 99 | 22 |
| Ezetimibe | Ezetimibe | 98 | 25 |
| Jardiance | Empagliflozin | 97 | 26 |
| Finasteride | Finasteride | 96 | 21 |
| Pregabalin | Pregabalin | 94 | 26 |
| Farxiga | Dapagliflozin Propanediol | 93 | 24 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 93 | 34 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 89 | 21 |
| Aripiprazole | Aripiprazole | 88 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 86 | 35 |
| Myrbetriq | Mirabegron | 84 | 11 |
| Torsemide | Torsemide | 83 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 79 | 23 |
| Testosterone Cypionate | Testosterone Cypionate | 79 | 21 |
| Propranolol Hcl | Propranolol Hcl | 78 | 26 |
| Azithromycin | Azithromycin | 77 | 67 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 77 | 26 |
| Synthroid | Levothyroxine Sodium | 77 | 23 |
| Bumetanide | Bumetanide | 76 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 75 | 16 |
| Estradiol | Estradiol | 75 | 21 |
| Doxepin Hcl | Doxepin Hcl | 73 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 72 | 22 |
| Glimepiride | Glimepiride | 70 | 23 |
| Amiodarone Hcl | Amiodarone Hcl | 69 | 15 |
| Baclofen | Baclofen | 63 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 62 | 49 |
| Glipizide Er | Glipizide | 62 | 18 |
| Cefdinir | Cefdinir | 61 | 41 |
| Cephalexin | Cephalexin | 60 | 36 |
| Diclofenac Sodium | Diclofenac Sodium | 58 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 58 | 32 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 56 | 11 |
| Trulicity | Dulaglutide | 56 | 19 |
| Nitroglycerin | Nitroglycerin | 54 | 38 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 53 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 53 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 52 | 15 |
| Levofloxacin | Levofloxacin | 51 | 37 |
| Tradjenta | Linagliptin | 51 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 50 | 33 |
| Benazepril Hcl | Benazepril Hcl | 48 | 13 |
| Lovastatin | Lovastatin | 48 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 48 | 36 |
| Topiramate | Topiramate | 48 | 15 |
| Amoxicillin | Amoxicillin | 47 | 38 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 47 | 13 |
| Fenofibrate | Fenofibrate,micronized | 47 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 46 | suppressed |
| Nystatin | Nystatin | 45 | 27 |
| Warfarin Sodium | Warfarin Sodium | 45 | 11 |
| Entresto | Sacubitril/Valsartan | 43 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 42 | 14 |
| Novolin R | Insulin Regular, Human | 42 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 42 | suppressed |
| Lorazepam | Lorazepam | 40 | 15 |
| Ondansetron Odt | Ondansetron | 40 | 17 |
| Celecoxib | Celecoxib | 39 | 17 |
| Latanoprost | Latanoprost | 39 | 12 |
| Cilostazol | Cilostazol | 38 | suppressed |
| Fluconazole | Fluconazole | 38 | 28 |
| Metoclopramide Hcl | Metoclopramide Hcl | 38 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 37 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 37 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 36 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 26 |
| Enalapril Maleate | Enalapril Maleate | 35 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 35 | 11 |
| Primidone | Primidone | 35 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 34 | 12 |
| Gemfibrozil | Gemfibrozil | 34 | 12 |
| Irbesartan | Irbesartan | 34 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 34 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 33 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | suppressed |
| Linzess | Linaclotide | 33 | suppressed |
| Naproxen | Naproxen | 33 | 11 |
| Valsartan | Valsartan | 33 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 33 | suppressed |
| Lactulose | Lactulose | 32 | 12 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 32 | suppressed |
| Bupropion Xl | Bupropion Hcl | 31 | 11 |
| Divalproex Sodium Er | Divalproex Sodium | 31 | 11 |
| Ranolazine Er | Ranolazine | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 27 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 30 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | 13 |
| Symbicort | Budesonide/Formoterol Fumarate | 30 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 29 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 29 | suppressed |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Rivastigmine | Rivastigmine | 28 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 27 | 23 |
| Methocarbamol | Methocarbamol | 27 | 13 |
| Methylprednisolone | Methylprednisolone | 27 | 13 |
| Midodrine Hcl | Midodrine Hcl | 27 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 25 | suppressed |
| Digoxin | Digoxin | 25 | suppressed |
| Humalog | Insulin Lispro | 25 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 15 |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Mounjaro | Tirzepatide | 24 | suppressed |
| Progesterone | Progesterone, Micronized | 24 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 24 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 23 | suppressed |
| Colchicine | Colchicine | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Olanzapine | Olanzapine | 22 | suppressed |
| Risperidone | Risperidone | 22 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 21 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 21 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 20 | suppressed |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 20 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 20 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 19 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 19 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 19 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 18 | 11 |
| Diazepam | Diazepam | 18 | suppressed |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 18 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 18 | suppressed |
| Rexulti | Brexpiprazole | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Acyclovir | Acyclovir | 17 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 17 | 13 |
| Glyburide | Glyburide | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Phenobarbital | Phenobarbital | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Anastrozole | Anastrozole | 16 | suppressed |
| Humulin R | Insulin Regular, Human | 16 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 16 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 16 | suppressed |
| Nystop | Nystatin | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 15 | 13 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Haloperidol | Haloperidol | 15 | suppressed |
| Insulin Lispro | Insulin Lispro | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 13 |
| Risedronate Sodium | Risedronate Sodium | 15 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 15 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Eszopiclone | Eszopiclone | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Testosterone | Testosterone | 14 | suppressed |
| Armour Thyroid | Thyroid,pork | 13 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Ibu | Ibuprofen | 13 | suppressed |
| Indomethacin | Indomethacin | 13 | suppressed |
| Minoxidil | Minoxidil | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Dexamethasone | Dexamethasone | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | 11 |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 11 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 11 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $122.46 · 6 records | Novo Nordisk Inc | Dexcom G6 Transmitter, Flexitouch Plus, Nimbl, Ozempic, REXULTI, Rybelsus, The Cologuard Plus Collection Kit | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lundbeck LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error